Alison Bauerlein

Officer, Inogen Inc.

Companies

Sight Sciences, Inc.Chief operating officer Nov 13, 2025 to now¹
Sight Sciences, Inc.Chief financial officer Feb 16, 2024 to Nov 6, 2025²
Sight Sciences, Inc.Officer Apr 5, 2023 to May 11, 2023³
Pear Therapeutics (United States)Board member Dec 7, 2021 to Feb 17, 2023⁴
GelesisBoard member Jan 24, 2022 to May 9, 2022⁵
Inogen IncChief financial officer Apr 16, 2014 to Dec 3, 2021⁶
Inogen IncOfficer Feb 12, 2014 to Apr 2, 2014⁷

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Sight Sciences, Inc. SGHT664,709 shares⁸$5.8M at $8.76Jul 2, 2026
Inogen Inc INGN33,902 shares⁹$213.4K at $6.29Dec 1, 2021
Pear Therapeutics (United States)71,428 shares¹⁰Feb 15, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Jul 2, 2026Sold 24,184 shares at $5.36 of Sight Sciences, Inc.⁸
May 18, 2026Sold 12,728 shares at $5.12 of Sight Sciences, Inc.¹¹
Apr 2, 2026Sold 25,874 shares at $3.48 of Sight Sciences, Inc.¹²
Feb 3, 2026Granted 127,512 shares of Sight Sciences, Inc.¹³
Jan 6, 2026Sold 9,647 shares at $7.48 of Sight Sciences, Inc.¹⁴
Jan 5, 2026Sold 10,896 shares at $7.82 of Sight Sciences, Inc.¹⁴
Nov 11, 2025Granted 23,006 shares of Sight Sciences, Inc.¹⁵
Oct 2, 2025Sold 19,948 shares at $3.30 of Sight Sciences, Inc.¹⁶
Jul 2, 2025Sold 19,260 shares at $4.10 of Sight Sciences, Inc.¹⁷
May 19, 2025Sold 13,066 shares at $3.48 of Sight Sciences, Inc.¹⁸
Apr 2, 2025Sold 19,397 shares at $2.31 of Sight Sciences, Inc.¹⁹
Mar 11, 2025Granted 286,738 shares of Sight Sciences, Inc.²⁰
Jan 3, 2025Sold 10,102 shares at $3.52 of Sight Sciences, Inc.²¹
Oct 1, 2024Sold 10,130 shares at $6.08 of Sight Sciences, Inc.²²
Jul 2, 2024Sold 10,497 shares at $6.21 of Sight Sciences, Inc.²³
May 17, 2024Sold 13,066 shares at $5.42 of Sight Sciences, Inc.²⁴
Apr 3, 2024Sold 10,123 shares at $5.08 of Sight Sciences, Inc.²⁵
Feb 14, 2024Granted 315,421 shares of Sight Sciences, Inc.²⁶
May 9, 2023Granted 103,000 shares of Sight Sciences, Inc.²⁷
Feb 15, 2023Granted 71,428 shares of Pear Therapeutics (United States)¹⁰
May 6, 2022Granted 51,095 shares of CIK 1805087²⁸
Dec 1, 2021Shares withheld for tax 490 shares at $29.66 of Inogen Inc⁹
Dec 1, 2021Exercised options 546 shares of Inogen Inc⁹
Dec 15, 2020Sold 2,349 shares at $41.33 of Inogen Inc²⁹
Dec 15, 2020Sold 1,904 shares at $40.42 of Inogen Inc²⁹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARSight Sciences, Inc., Chief operating officer
2
SEC EDGARSight Sciences, Inc., Chief financial officer
3
SEC EDGARSight Sciences, Inc., Officer
4
SEC EDGARPear Therapeutics (United States), Board member
5
SEC EDGARGelesis, Board member
6
SEC EDGARInogen Inc, Chief financial officer
7
SEC EDGARInogen Inc, Officer
8
SEC EDGARSight Sciences, Inc. shares after the filing of Jul 2, 2026
9
SEC EDGARInogen Inc shares after the filing of Dec 1, 2021
10
SEC EDGARPear Therapeutics (United States) shares after the filing of Feb 15, 2023
11
SEC EDGARForm 4 filed May 19, 2026
12
SEC EDGARForm 4 filed Apr 3, 2026
13
SEC EDGARForm 4 filed Feb 5, 2026
14
SEC EDGARForm 4 filed Jan 6, 2026
15
SEC EDGARForm 4 filed Nov 13, 2025
16
SEC EDGARForm 4 filed Oct 3, 2025
17
SEC EDGARForm 4 filed Jul 7, 2025
18
SEC EDGARForm 4 filed May 21, 2025
19
SEC EDGARForm 4 filed Apr 3, 2025
20
SEC EDGARForm 4 filed Mar 13, 2025
21
SEC EDGARForm 4 filed Jan 6, 2025
22
SEC EDGARForm 4 filed Oct 3, 2024
23
SEC EDGARForm 4 filed Jul 3, 2024
24
SEC EDGARForm 4 filed May 20, 2024
25
SEC EDGARForm 4 filed Apr 4, 2024
26
SEC EDGARForm 4 filed Feb 16, 2024
27
SEC EDGARForm 4 filed May 11, 2023
28
SEC EDGARForm 4 filed May 9, 2022
29
SEC EDGARForm 4 filed Dec 3, 2021